arrow
M

Michael Hudecek

Universitätsklinikum Würzburg
H指数:49
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Longitudinal psychosocial burden, quality of life, and digital supportive care preferences before and after CAR T-cell therapy: a prospective single-center observational study

CAR T细胞治疗前后纵向心理社会负担、生活质量及数字支持性护理偏好的前瞻性单中心观察研究

2026-10-270
OAAI
Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination

通过亲和力组合平衡嵌合抗原受体T细胞疗法的有效性与安全性

2026-04-100
OA
Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapy

GPRC5D的缺失增强了抗GPRC5D免疫疗法下骨髓瘤的增殖能力和竞争适应性

Leukemia
IF13.4
2026-03-310
OAAI
Current capacity and gaps in viral vector manufacturing: a survey of centers associated with CTIWP of EBMT, NXTGEN-hightech, DARE-NL, T2EVOLVE, and GoCART coalition

病毒载体生产方面的当前产能与差距:对EBMT、NXTGEN-hightech、DARE-NL、T2EVOLVE和GoCART联盟相关中心的调查

2025-12-170
PRE
Endothelial dysfunction and proinflammatory state determine severe hematotoxicity and inferior outcome of CAR-T therapy

内皮功能障碍和促炎状态决定CAR-T疗法的严重血液毒性及较差的疗效

2025-12-080
OAAI
A novel dual-antigen CAR T cell strategy targeting PDPN and GD2 for the treatment of glioblastoma

一种靶向PDPN和GD2的新型双抗原CAR T细胞策略,用于胶质母细胞瘤的治疗

2025-11-010
OAAI
Improved Antitumor Activity of Interleukin-12-Secreting Chimeric Antigen Receptor T Cells Targeting CD176 across Different Carcinomas

靶向CD176的分泌白细胞介素-12的嵌合抗原受体T细胞在不同癌瘤中的抗肿瘤活性增强

2025-11-010
OA
Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe

欧洲接受CAR T细胞疗法治疗的血液恶性肿瘤患者的患者报告结局

2025-09-260
OAAI
Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma

血浆置换促进可溶性BCMA清除,并有助于逆转多发性骨髓瘤对BCMA免疫疗法的原发耐药。

Leukemia
IF13.4
2025-09-100
OAAI
Impact of Serum/Xeno-Free Medium and Cytokine Supplementation on CAR-T Cell Therapy Manufacturing in Stirred Tank Bioreactors

血清/无血清培养基及细胞因子补充对搅拌式生物反应器中CAR-T细胞疗法生产的影响

2025-09-090
OAAI
Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapies

工程化嵌合细胞免疫疗法中生物医学虚拟双胞胎的设计规范

2025-08-010
OAAI
Boosting CAR T-Cell Efficacy by Blocking Proteasomal Degradation of Membrane Antigens

通过阻断膜抗原的蛋白酶体降解来增强CAR T细胞疗效

Blood
IF23.1
2025-07-140
OAAI
A fully human In-vitro model for bone metastasis: potential of an electrospun scaffold as alternative to biological materials for osteoblast/osteoclast differentiation

一种用于骨转移的全人源体外模型:电纺支架作为替代生物材料用于成骨细胞/破骨细胞分化的潜力

2025-05-220
PRE